EMTRIVA Safety Questions, EMTRIVA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about EMTRIVA. Our extensive database of EMTRIVA adverse events and EMTRIVA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about EMTRIVA
EMTRIVA Safety Reports
Total EMTRIVA reports: 21.EMTRIVA FDA safety alerts: No.
Reported hospitalizations: 16.
Take EMTRIVA Side Effects Survey or Share Your EMTRIVA Story. EMTRIVA Usage.
Health Professional from FRANCE reported EMTRIVA problem on Jan 08, 2007. Male patient, 53 years of age, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. EMTRIVA dosage: unknown. During the same period patient was treated with SUSTIVA, KALETRA, ASPEGIC, TRIATEC, PLAVIX, SECTRAL. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from FRANCE on Jan 09, 2007. Male patient, 47 years of age, weighting 169.8 lb, was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: haemoglobinaemia, photosensitivity reaction, pruritus. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, ZELITREX, NORVIR, REYATAZ, BACLOFENE IREX, MIXTARD, ATATRAX, BACTRIM. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMTRIVA problem on Feb 02, 2007. Female patient, 19 years of age, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: pre-eclampsia, pregnancy. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, RETROVIR, SUSTIVA. Patient recovered.
EMTRIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 19 years of age, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: pre-eclampsia, pregnancy. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, RETROVIR, SUSTIVA, TRIZIVIR. Patient recovered.
Physician from MEXICO reported EMTRIVA problem on Mar 28, 2007. Male patient, weighting 119.0 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, EFAVIRENZ. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from SPAIN on May 29, 2007. Male patient, 41 years of age, was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, VIRAMUNE. Patient recovered.
Health Professional from FRANCE reported EMTRIVA problem on May 16, 2006. Male patient, 43 years of age, weighting 156.5 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, cytology abnormal, hyperthermia, pyrexia, rash maculo-papular, toxic skin eruption. EMTRIVA dosage: unknown. During the same period patient was treated with TELZIR, RETROVIR, NORVIR. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from FRANCE on July 27, 2006. Female patient, 40 years of age, weighting 147.7 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: abortion induced, blood alkaline phosphatase increased, bone disorder, hypophosphataemia, pregnancy. EMTRIVA dosage: unknown. During the same period patient was treated with NORVIR, REYATAZ, SEROPRAM, LEXOMIL. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported EMTRIVA problem on May 22, 2006. Male patient, weighting 119.0 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, chondropathy, osteonecrosis. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, SUSTIVA. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from JAPAN on May 21, 2006. Male patient, 35 years of age, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: arthralgia, haemarthrosis, haematospermia, haematuria. EMTRIVA dosage: unknown. During the same period patient was treated with VIRAMUNE, RETROVIR, ALINAMIN, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported EMTRIVA problem on Oct 09, 2006. Male patient, 50 years of age, weighting 143.3 lb, was diagnosed with candidiasis and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, hyperlactacidaemia, monoparesis, myositis, oedema peripheral. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, RITONAVIR, FOSAMPRENAVIR, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from FRANCE on Oct 27, 2006. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, granulomatous liver disease, hepatic enzyme increased, immune reconstitution syndrome, macrophage activation, ocular icterus, oesophageal candidiasis, pyrexia. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, SUSTIVA, BACTRIM, ZECLAR, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMTRIVA problem on Nov 14, 2006. Male patient, 31 years of age, weighting 131.8 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: hepatic encephalopathy. EMTRIVA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, SUSTIVA, COTRIM D, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from UNITED KINGDOM on Nov 24, 2006. Male patient, 37 years of age, weighting 125.7 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, NORVIR, TELZIR. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EMTRIVA problem on Nov 14, 2006. Male patient, 31 years of age, weighting 131.8 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: acid fast bacilli infection, anorexia, asthenia, chest pain, confusional state, diarrhoea, eructation, haematocrit decreased, haemoglobin decreased. EMTRIVA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, SUSTIVA, COTRIM D, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
EMTRIVA problem was reported by a Health Professional from UNITED KINGDOM on Oct 09, 2006. Male patient, 50 years of age, weighting 143.3 lb, was diagnosed with candidiasis and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, hyperlactacidaemia, monoparesis, myositis, oedema peripheral. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, RITONAVIR, FOSAMPRENAVIR, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported EMTRIVA problem on Aug 07, 2007. Male patient, weighting 167.6 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: liver disorder. EMTRIVA dosage: unknown. During the same period patient was treated with VIRAMUNE, VIREAD, MORPHINE SULPHATE. Patient recovered.
EMTRIVA problem was reported by a Physician from MEXICO on Aug 13, 2007. Male patient, weighting 138.9 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, dehydration, diarrhoea, nausea, vomiting. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, SAQUINAVIR, RITONAVIR, TRIMETHOPRIM. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported EMTRIVA problem on Aug 20, 2007. Male patient, weighting 167.6 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: liver disorder. EMTRIVA dosage: unknown. During the same period patient was treated with VIRAMUNE, VIREAD, MORPHINE SULPHATE. Patient recovered.
EMTRIVA problem was reported by a Health Professional from FRANCE on Sept 03, 2007. Male patient, weighting 165.3 lb, was diagnosed with hiv infection, muscle spasms and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, antinuclear antibody positive, bilirubin conjugated increased, blood bilirubin increased, epidermal necrosis, haemoglobinaemia, hair colour changes, lymphoproliferative disorder. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, TRUVADA, HEXAQUINE, NORVIR, REYATAZ, ZELITREX, MIXTARD, ATATRAX. Patient was hospitalized and became disabled. Patient recovered.
Physician from MEXICO reported EMTRIVA problem on Sept 11, 2007. Male patient, weighting 138.9 lb, was diagnosed with hiv infection and was treated with EMTRIVA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, dehydration. EMTRIVA dosage: unknown. During the same period patient was treated with VIREAD, SAQUINAVIR, RITONAVIR, TRIMETHOPRIM. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert